WO2026105035 - ANTIBODY PURIFICATION BY A MULTI CHROMATOGRAPHY PROCESS
National phase entry is expected:
Publication Number
WO/2026/105035
Publication Date
21.05.2026
International Application No.
PCT/IB2025/061611
International Filing Date
13.11.2025
Title **
[English]
ANTIBODY PURIFICATION BY A MULTI CHROMATOGRAPHY PROCESS
[French]
PURIFICATION D'ANTICORPS PAR UN PROCÉDÉ DE CHROMATOGRAPHIE MULTIPLE
Applicants **
H. LUNDBECK A/S
Inventors
OJALA, Ethan Wayne
MARZOLF, Sam
MALISAUSKAS, Mantas
Priority Data
63/720,471
14.11.2024
US
63/855,595
01.08.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2609 | |
| EPO | Filing, Examination, Granting | 16993 | |
| Japan | Filing, Examination, Granting | 2679 | |
| South Korea | Filing, Examination, Granting | 3174 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
32,595
Contact Us
Abstract[English]
The present invention relates to methods for isolating a product and/or reducing impurities such as Host Cell Proteins (HCP), aggregates and residual Protein A (rPA) from a load fluid comprising a FC-containing proteins. 5[French]
La présente invention concerne des procédés pour isoler un produit et/ou réduire des impuretés telles que des protéines de cellules hôtes (HCP), des agrégats et la protéine A résiduelle (rPA) à partir d'un fluide de charge comprenant des protéines contenant un fragment Fc. 5